Placebo (n =1544) | Salmeterol (n =1542) | FP (n =1552) | SFC (n =1546) | |
Patients with ischaemic CV AE, n (%) | 166 (11) | 166 (11) | 167 (11) | 144 (9) |
Rate* of ischaemic CV AE (no of events) | 68 (224) | 70 (240) | 62 (222) | 54 (199) |
Probability† of ischaemic CV AE by 3 years, % | 14.6 | 13.4 | 13.8 | 11.3 |
Hazard ratio | 95% CI | p Value | |
SFC vs placebo | 0.76 | 0.61 to 0.95 | 0.016 |
Salmeterol vs placebo | 0.93 | 0.75 to 1.16 | 0.531 |
FP vs placebo | 0.93 | 0.75 to 1.15 | 0.477 |